Active Filter(s):
Details:
Under the agreement, Meridian will supply DuoDote to the Administration for Strategic Preparedness and Response within the United States. DuoDote® is an FDA-approved dual-chamber autoinjector (atropine and pralidoxime chloride) chemical nerve agent antidote.
Lead Product(s): Atropine,Pralidoxime Chloride
Therapeutic Area: Pharmacology/Toxicology Product Name: DuoDote
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: ASPR
Deal Size: $9.9 million Upfront Cash: Undisclosed
Deal Type: Agreement November 14, 2023